GLP3 · 30 mg
Triple-agonist research peptide studied for GIP, GLP-1 and glucagon receptor activity in metabolic models.
$169.00$249.00
Metabolic Research
Cagrilintide 5 mg
$69.00$129.0099.8% purity · Batch Cag-260727
Long-acting amylin analogue studied in appetite-regulation and metabolic research models.
Lot analysis published for this batch. Independent Janoshik Analytical testing (Aug 2026) — purity, content and endotoxin, shown unedited further down this page.1
- Third-party HPLC & mass-spec verified
- Same-day dispatch before 2 PM ET
- Cold-packed, tamper-sealed shipping
- Batch-coded and dated at fill
Research background
Cagrilintide is a long-acting amylin receptor agonist investigated in metabolic and energy-homeostasis research, frequently referenced alongside incretin-pathway compounds. Supplied lyophilised in a sealed, lot-coded vial; the published lot report lists measured content and purity for this batch.
Research use only. This product is supplied strictly for in-vitro laboratory research by qualified professionals. It is not a drug, food or cosmetic and must not be administered to humans or animals.
Lot analysis for this batch
- Lot
- Cag-260727
- Purity (3 vials)
- 99.84 / 99.80 / 99.78 %
- Content (3 vials)
- 5.25 / 5.28 / 5.35 mg
- Endotoxin
- Not requested on this lot
- Tested by
- Janoshik Analytical, Aug 2026
Published in full and unedited — verify it with the key printed on the report.
Specifications
- Molecular formula
- C194H312N54O59S2
- Molar mass
- 4409.0 g/mol
- Form
- Lyophilised white powder
- Storage
- -20 °C, protect from light
- Certificate of analysis
- View batch Cag-260727
More in Metabolic Research
GLP2 · 30 mg
Dual GIP/GLP-1 receptor research peptide in a 30 mg batch-coded vial, with its lot report published in full.
$89.00$139.00
Tesamorelin · 10 mg
Growth hormone-releasing factor analogue studied in metabolic and body-composition research models.
$95.00$169.00
Cagrilintide 5 mg
$69.00